Board to consider Sub-division of Equity Shares
Caplin Point Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 05, 2016, inter alia:- To consider the sub division of equity shares of Rs. 10/- each into equity shares with a lower face value.Further, the Trading Window for dealing in the equity shares of the Company is already closed for Promoters, Directors, other Connected Persons and Employees of the Company from June... Shareholding for the Period Ended June 30, 2016
Caplin Point Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Caplin Point Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Caplin Point an attractive bet
There are a number of similarities between Caplin and Ajanta Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
May India Property Pvt Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Results Press Release for March 31, 2016
Caplin Point Laboratories Ltd has informed BSE about : 1. Result Press Release for the period ended March 31, 2016 Standalone & Consolidated Financial Results, Form A, Auditors Report for March 31, 2016
Caplin Point Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Consolidated Financial Results for the period ended March 31, 20163. Standalone Form A for the period ended March 31, 20164. Standalone Auditors Report for the period ended March 31, 20165. Consolidated Auditors Report for the period ended March 31, 2016 Board recommends Final Dividend
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2016, have recommended a Final Dividend of Rs. 3.50 (35%) on the face value of Rs. 10 each for Nine months/Financial Year ended March 31, 2016. Board to consider Final Dividend
Caplin Point Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 27, 2016, inter alia:1. To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Third Quarter ended March 31, 2016 and Nine Months / Financial Year ended March 31, 2016;and...